These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6436861

  • 1. The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.
    Hagstadius S, Gustafson L, Risberg J.
    Psychopharmacology (Berl); 1984; 83(4):321-6. PubMed ID: 6436861
    [Abstract] [Full Text] [Related]

  • 2. Effects of piracetam on regional cerebral blood flow and mental functions in patients with organic dementia.
    Gustafson L, Risberg J, Johanson M, Fransson M, Maximilian VA.
    Psychopharmacology (Berl); 1978 Mar 01; 56(2):115-7. PubMed ID: 417361
    [Abstract] [Full Text] [Related]

  • 3. [The effect of vincamine on cerebral blood flow as a function of application rate (author's transl)].
    Heiss WD, Podreka I, Samec P.
    Arzneimittelforschung; 1977 Mar 01; 27(6a):1291-3. PubMed ID: 578455
    [Abstract] [Full Text] [Related]

  • 4. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers.
    Lim CC, Cook PJ, James IM.
    Br J Clin Pharmacol; 1980 Jan 01; 9(1):100-1. PubMed ID: 7356869
    [No Abstract] [Full Text] [Related]

  • 5. [The influence of vincamine on global and regional cerebral blood flow in acute and subchronic human cerebral ischimia (author's transl)].
    Herrschaft H.
    Arzneimittelforschung; 1977 Jan 01; 27(6a):1278-84. PubMed ID: 578453
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationship of vindeburnol based on spectral analysis of posturographic recordings.
    Patat A, Le Go A, Foulhoux P.
    Eur J Clin Pharmacol; 1985 Jan 01; 29(4):455-9. PubMed ID: 3912189
    [Abstract] [Full Text] [Related]

  • 7. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L, Roca J, Balasch J.
    Arch Farmacol Toxicol; 1978 Aug 01; 4(2):261-4. PubMed ID: 727839
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F, Dragonetti M, Formento ML, Gueniau C, Nencioni A, Mantegazza P.
    Arzneimittelforschung; 1986 Oct 01; 36(10):1442-8. PubMed ID: 3814205
    [Abstract] [Full Text] [Related]

  • 9. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T.
    Nihon Rinsho; 1985 Feb 01; 43(2):389-91. PubMed ID: 3889412
    [No Abstract] [Full Text] [Related]

  • 10. Effects of brovincamine on the stereological parameters of corticocerebral capillaries.
    Meier-Ruge W, Schulz-Dazzi U.
    Life Sci; 1987 Mar 09; 40(10):943-9. PubMed ID: 3821365
    [Abstract] [Full Text] [Related]

  • 11. The effect of vincamine on the regional cerebral blood flow in man.
    Depresseux JC.
    Eur Neurol; 1978 Mar 09; 17(2):100-7. PubMed ID: 631141
    [Abstract] [Full Text] [Related]

  • 12. Cerebral metabolic and hemodynamic activities of l-eburnamonine in the anesthetized dog. A comparison with vincamine.
    Lacroix P, Quiniou MJ, Linee P, Le Polles JB.
    Arzneimittelforschung; 1979 Mar 09; 29(8):1094-101. PubMed ID: 40580
    [Abstract] [Full Text] [Related]

  • 13. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M, Magnani G, Sinforiani E, Casali R.
    Int J Clin Pharmacol Res; 1984 Mar 09; 4(4):307-12. PubMed ID: 6389380
    [Abstract] [Full Text] [Related]

  • 14. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
    Knezevic S, Mubrin Z, Risberg J, Vucinic G, Spilich G, Gubarev N, Wannenmacher W.
    Int Clin Psychopharmacol; 1989 Jan 09; 4(1):25-38. PubMed ID: 2687355
    [Abstract] [Full Text] [Related]

  • 15. Acute i.v. vincamine teprosilate administration: quantified investigation in elderly subjects.
    Moglia A, Alfonsi E, Zandrini C, Pistarini C, Arrigo A.
    Int J Clin Pharmacol Res; 1984 Jan 09; 4(4):303-6. PubMed ID: 6500777
    [Abstract] [Full Text] [Related]

  • 16. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
    Miyazaki M.
    Jpn Circ J; 1978 Apr 09; 42(4):433-40. PubMed ID: 702768
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
    Kawashima Y, Ikemoto T, Horiguchi A, Hayashi M, Matsumoto K, Kawarasaki K, Yamazaki R, Okuyama S, Hatayama K.
    J Med Chem; 1993 Apr 02; 36(7):815-9. PubMed ID: 8464035
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the activity of vindeburnol by spectral analysis of human EEG].
    Patat A, Klein MJ.
    Therapie; 1986 Apr 02; 41(4):305-10. PubMed ID: 3554597
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of pharmacological effects on cerebral blood flow.
    Heiss WD, Podreka I.
    Eur Neurol; 1978 Apr 02; 17 Suppl 1():135-43. PubMed ID: 753629
    [Abstract] [Full Text] [Related]

  • 20. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK, Blechacz W.
    Arzneimittelforschung; 1977 Apr 02; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.